Advertisement

Current Anesthesiology Reports

, Volume 5, Issue 4, pp 429–437 | Cite as

Echocardiography for Electrophysiology Procedures

  • Carly Peterson
  • Jordan M. Prutkin
  • Melissa Robinson
  • Michael Hall
  • Renata G. FerreiraEmail author
Cardiovascular Anesthesia (A Mahajan, Section Editor)
Part of the following topical collections:
  1. Cardiovascular Anesthesia

Abstract

Technological advances have improved the care of patients in many areas of medicine including the electrophysiology (EP) laboratory. The incidence of arrhythmias is increasing, and EP procedures are rapidly evolving to meet these needs. Echocardiography plays an essential role not only in assessment and planning but also in real-time monitoring of these procedures. Echocardiographers have become an important part of the planning and execution of a variety of procedures in the EP lab. Different echocardiography modalities, including TTE, TEE, and ICE, are utilized in the periprocedure settings. The complexity of medical conditions and procedures has led to increasing demands on the care provided by anesthesiologists. This article summarizes the most common EP procedures and the different modalities of echocardiography required for successful outcomes.

Keywords

Echocardiography ICE Electrophysiology 

Notes

Supplementary material

Video 1

TEE video illustrating thrombus in the left atrial appendage. On the left is a 2D video of the midesophageal 2 chamber view. On the right is a 3D TEE image of the clot within the appendage

Video 2

2D TEE transgastric short axis view after a lead perforation demonstrating a large pericardial effusion with RV collapse confirming tamponade physiology

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Go AS, et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–292.CrossRefPubMedGoogle Scholar
  2. 2.
    Roger VL, et al. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–209.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Buch E, Boyle NG, Belott PH. Pacemaker and defibrillator lead extraction. Circulation. 2011;123(11):e378–80.CrossRefPubMedGoogle Scholar
  4. 4.
    Ewy GA. Sick sinus syndrome: synopsis. J Am Coll Cardiol. 2014;64(6):539–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127(3):e283–352.CrossRefPubMedGoogle Scholar
  6. 6.
    Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345(20):1473–82.CrossRefPubMedGoogle Scholar
  7. 7.
    Khazanie P, et al. Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE. Circ Heart Fail. 2014;7(6):926–34.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Komajda M. Current challenges in the management of heart failure. Circ J. 2015;79(5):948–53.CrossRefPubMedGoogle Scholar
  9. 9.
    Bardy GH, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.CrossRefPubMedGoogle Scholar
  10. 10.
    Zipes DP et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337(22):1576–83.Google Scholar
  11. 11.
    Moss AJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83.CrossRefPubMedGoogle Scholar
  12. 12.
    Chung ES, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608–16.CrossRefPubMedGoogle Scholar
  13. 13.
    Leyva F, Nisam S, Auricchio A. 20 years of cardiac resynchronization therapy. J Am Coll Cardiol. 2014;64(10):1047–58.CrossRefPubMedGoogle Scholar
  14. 14.
    Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75.CrossRefPubMedGoogle Scholar
  15. 15.
    Khairy P, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11(10):e102–65.CrossRefPubMedGoogle Scholar
  16. 16.
    Pediatric and Congenital Electrophysiology Society (PACES), et al. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm. 2012;9(6):1006–24.CrossRefGoogle Scholar
  17. 17.
    Cappato R, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–8.CrossRefPubMedGoogle Scholar
  18. 18.
    • Blomstrom-Lundqvist C, et al. The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology. Europace, 2013;15(7):927–36. An updated guideline that highlights the indications of echocardiography for electrophysiological and devices procedures. Google Scholar
  19. 19.
    Blomstrom-Lundqvist C, et al. The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology. Europace. 2013;15(7):927–36.CrossRefPubMedGoogle Scholar
  20. 20.
    Fuster V, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57(11):e101–98.CrossRefPubMedGoogle Scholar
  21. 21.
    Camm AJ, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10):1385–413.CrossRefPubMedGoogle Scholar
  22. 22.
    Friberg L, Bergfeldt L. Atrial fibrillation prevalence revisited. J Intern Med. 2013;274(5):461–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Schnabel RB, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015. doi: 10.1016/S0140-6736(14)61774-8.PubMedCentralGoogle Scholar
  24. 24.
    Priester R, et al. Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009;104(9):1256–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Di Biase L, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. Circulation. 2014;129(25):2638–44.CrossRefPubMedGoogle Scholar
  26. 26.
    Ren JF, et al. Intracardiac echocardiographic diagnosis of thrombus formation in the left atrial appendage: a complementary role to transesophageal echocardiography. Echocardiography. 2013;30(1):72–80.CrossRefPubMedGoogle Scholar
  27. 27.
    Zabalgoitia M, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998;31(7):1622–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Budoff MJ, et al. Comparison of transesophageal echocardiography versus computed tomography for detection of left atrial appendage filling defect (thrombus). Am J Cardiol. 2014;113(1):173–7.CrossRefPubMedGoogle Scholar
  29. 29.
    European Heart Rhythm. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.CrossRefGoogle Scholar
  30. 30.
    Holmes DR Jr, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65(24):2614–23.CrossRefPubMedGoogle Scholar
  31. 31.
    Shin SH, et al. Left atrial volume is a predictor of atrial fibrillation recurrence after catheter ablation. J Am Soc Echocardiogr. 2008;21(6):697–702.CrossRefPubMedGoogle Scholar
  32. 32.
    Pison L, et al. Imaging techniques in electrophysiology and implantable device procedures: results of the European Heart Rhythm Association survey. Europace. 2013;15(9):1333–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Mountantonakis SE, et al. Provocation of atrial fibrillation triggers during ablation: does the use of general anesthesia affect inducibility? J Cardiovasc Electrophysiol. 2015;26(1):16–20.CrossRefPubMedGoogle Scholar
  34. 34.
    •• Neelankavil J, et al. Intracardiac echocardiography. J Cardiothorac Vasc Anesth, 2015;29(2):502–5. This very interesting article article reports indications, techniches and complications of intracradiac echocardiography while ilustrating with case reports. Google Scholar
  35. 35.
    Silvestry FE, et al. Echocardiography-guided interventions. J Am Soc Echocardiogr. 2009;22(3):213–31 quiz 316-7.CrossRefPubMedGoogle Scholar
  36. 36.
    Baran J, et al. Intracardiac echocardiography for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the Action-Ice I Study. Circ Arrhythm Electrophysiol. 2013;6(6):1074–81.CrossRefPubMedGoogle Scholar
  37. 37.
    Reddy VY, Neuzil P, Ruskin JN. Intracardiac echocardiographic imaging of the left atrial appendage. Heart Rhythm. 2005;2(11):1272–3.CrossRefPubMedGoogle Scholar
  38. 38.
    Tanawuttiwat T, Gallego D, Carrillo RG. Lead extraction experience with high frequency excimer laser. Pacing Clin Electrophysiol. 2014;37(9):1120–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Di Monaco A, et al. Safety of transvenous lead extraction according to centre volume: a systematic review and meta-analysis. Europace. 2014;16(10):1496–507.CrossRefPubMedGoogle Scholar
  40. 40.
    Kerut EK, Hanawalt C, McKinnie J. Transesophageal echocardiography during pulmonary vein cryoballoon ablation for atrial fibrillation. Echocardiography. 2015;32(2):281–90.CrossRefPubMedGoogle Scholar
  41. 41.
    Kumar S, et al. The transesophageal echo probe may contribute to esophageal injury after catheter ablation for paroxysmal atrial fibrillation under general anesthesia: a preliminary observation. J Cardiovasc Electrophysiol. 2015;26(2):119–26.CrossRefPubMedGoogle Scholar
  42. 42.
    Ottaviano L, et al. Cryoballoon ablation for atrial fibrillation guided by real-time three-dimensional transoesophageal echocardiography: a feasibility study. Europace. 2013;15(7):944–50.CrossRefPubMedGoogle Scholar
  43. 43.
    Acena M, et al. 3D real-time TEE during pulmonary vein isolation in atrial fibrillation. JACC Cardiovasc Imaging. 2014;7(7):737–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Laura DM, et al. The role of multimodality imaging in percutaneous left atrial appendage suture ligation with the LARIAT device. J Am Soc Echocardiogr. 2014;27(7):699–708.CrossRefPubMedGoogle Scholar
  45. 45.
    Wilkoff BL, et al. Transvenous lead extraction: heart rhythm society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6(7):1085–104.CrossRefPubMedGoogle Scholar
  46. 46.
    Yang HS, et al. Images in cardiovascular medicine. Real-time 3-dimensional transesophageal echocardiography: novel utility in atrial fibrillation ablation with a prosthetic mitral valve. Circulation. 2008;117(14):e304–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Balzer J, Kelm M, Kuhl HP. Real-time three-dimensional transoesophageal echocardiography for guidance of non-coronary interventions in the catheter laboratory. Eur J Echocardiogr. 2009;10(3):341–9.CrossRefPubMedGoogle Scholar
  48. 48.
    Brysiewicz N, et al. 3D real-time intracardiac echocardiographic visualization of atrial structures relevant to atrial fibrillation ablation. JACC Cardiovasc Imaging. 2014;7(1):97–100.CrossRefPubMedGoogle Scholar
  49. 49.
    Baddour LM, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–77.CrossRefPubMedGoogle Scholar
  50. 50.
    Marelli A, et al. Estimating the congenital heart disease population in the United States in 2010—what are the numbers? J Am Coll Cardiol. 2012;59(13s1):E787–E787.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media New York 2015

Authors and Affiliations

  • Carly Peterson
    • 1
  • Jordan M. Prutkin
    • 2
  • Melissa Robinson
    • 2
  • Michael Hall
    • 1
  • Renata G. Ferreira
    • 1
    Email author
  1. 1.Division of Cardiothoracic Anesthesiology, Department of Anesthesiology & Pain MedicineUniversity of WashingtonSeattleUSA
  2. 2.Division of CardiologyUniversity of WashingtonSeattleUSA

Personalised recommendations